F41.2 F31 F32 F33
Conditions
Interventions
Group 1: For one night, patients receive an open-Label Placebo pill instead of their usual sleep medication. A detailed Information about effects and side effects in Terms of "informed consent" is per
Sponsors
Klinikum rechts der Isar der TU München
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Diagnosis of a depressive disorder (ICD-10: F31, F32, F33 oder F41). Documented sleep disorder. Sleep medication. Inpatient Treatment for at least 7 days.
Exclusion criteria
Exclusion criteria: Not able to give written consent. Suicidiality.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the amount of impairment by side effects through the new medication indicated on a visual analogue scale. Values vary from 1 (not at all) to 10 (a lot). The Rating takes place in the morning after the Placebo Administration. | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective Quality of Sleep. The rating takes place in the morning after the placebo administration using an in-house questionnaire that is routinely used in the somnological department of our clinic. | — |
Countries
Germany
Contacts
Public ContactFabian Holzhüter
Klinik und Poliklinik für Psychiatrie und Psychotherapie des Klinikums rechts der Isar der TU München
Outcome results
None listed